CymaBay Therapeutics, Inc.

Report date
12/31/2023
Quarter
2023 Q4
Filed
2/26/2024
Shares
4,024,400
Value ($000)
95,056
Weight
2.1%
2022 Q4 - 2023 Q4 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).